Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
European Journal of Clinical Pharmacology|September 21, 2002
Concomitant use of mirtazapine and phenytoin: a drug-drug interaction study in healthy male subjectsE Spaans, M W van den Heuvel, P G Schnabel, et al.
European Journal of Pediatrics|October 31, 2018
Central nervous system-active drug abused and overdose in children: a worldwide exploratory study using the WHO pharmacovigilance databaseCarla Carnovale, Faizan Mahzar, Sara Scibelli, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 24, 2010
Metabolism and excretion of asenapine in healthy male subjectsS F M van de Wetering-Krebbers, P L Jacobs, G J Kemperman, et al.
Clinical and Translational Science|July 28, 2018
Assessment of Dermal Absorption of Aluminum from a Representative Antiperspirant Formulation Using a 26 Al Microtracer ApproachRianne de Ligt, Esther van Duijn, Dimitri Grossouw, et al.
Journal of Psychopharmacology (Oxford, England)|February 12, 2010
A pharmacological tool to assess vasopressinergic co-activation of the hypothalamus-pituitary-adrenal axis more integrally in healthy volunteersG E Jacobs, J M A van Gerven, M l de Kam, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 6, 2025
Design and rationale of the South-East Netherlands Heart Registry (ZON-HR)Eva C I Woelders, Denise A M Peeters, Sanne Janssen, et al.
International Journal of Clinical Practice|June 2, 2020
Nicolau syndrome caused by non-steroidal anti-inflammatory drugs: Systematic literature reviewPietro F Lardelli, Luca M M Jermini, Gregorio P Milani, et al.
Journal of Psychopharmacology (Oxford, England)|February 10, 2010
Desmopressin as a pharmacological tool in vasopressinergic hypothalamus-pituitary-adrenal axis modulation: neuroendocrine, cardiovascular and coagulatory effectsG E Jacobs, E G J Hulskotte, J M A van Gerven, et al.
Frontiers in Cardiovascular Medicine|February 19, 2024
Invasive coronary imaging of inflammation to further characterize high-risk lesions: what options do we have?Jonathan Los, Frans B Mensink, Niekbachsh Mohammadnia, et al.
International Journal of Cardiology. Heart & Vasculature|December 9, 2024
Rationale and design of the STOP-IMH randomised trial: Safety of ticagrelor monotherapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction and the effect on intramyocardial haemorrhageE C I Woelders, B Yosofi, D A M Peeters, et al.
Pageof 4